Interpretation of Laboratory Results for a 23-Year-Old Female Patient
The laboratory results indicate Polycystic Ovary Syndrome (PCOS) with insulin resistance as the most likely diagnosis, characterized by low SHBG, elevated insulin, and normal free testosterone despite low-normal total testosterone.
Laboratory Findings Analysis
Key Abnormal Results:
- Sex Hormone Binding Globulin (SHBG): 19.2 nmol/L (low, reference range: 24.6-122.0)
- Insulin Total Random: 33.2 uIU/mL (elevated, reference range: 2.6-24.9)
- Total Testosterone: 20.30 ng/dL (low-normal, reference range: 8.00-48.00)
Normal Results:
- Free Testosterone: 5 pg/mL (normal, reference range: 1-7)
- Bioavailable Testosterone: 11 ng/dL (normal, reference range: 2-21)
- Free Testosterone Percent: 2.31% (normal, reference range: 1.60-2.90)
- Prolactin: 20.00 ng/mL (normal, reference range: 4.79-23.30)
- DHEA: 346 ng/dL (normal)
- 17-Hydroxyprogesterone: 26.26 ng/dL (normal, reference range: ≤206.00)
Clinical Significance
Low SHBG with Normal Free Testosterone:
Elevated Insulin:
Management Approach
Diagnostic Confirmation
- Assess for other PCOS criteria:
First-Line Treatment: Lifestyle Modifications
- Weight management is critical for improving insulin sensitivity and SHBG levels 7
- Recommend:
Medication Considerations
- Metformin may be indicated to improve insulin sensitivity
- Combined oral contraceptives can be considered to:
- Regulate menstrual cycles
- Increase SHBG levels
- Reduce free androgen levels
Monitoring
- Follow-up in 3-6 months to assess:
- Insulin levels
- SHBG levels
- Free and total testosterone
- Clinical symptoms (menstrual regularity, hirsutism)
Clinical Pearls and Pitfalls
- Important: Free testosterone calculation is more reliable than Free Androgen Index (FAI) for monitoring bioavailable testosterone 3
- Caution: Normal free testosterone with low SHBG can mask underlying hormonal imbalances if only total testosterone is measured 2
- Remember: Insulin resistance and low SHBG are independently associated with metabolic syndrome and cardiovascular risk 5, 6
- Note: The pathogenesis of PCOS involves acceleration of pulsatile GnRH secretion, insulin resistance, and downstream metabolic dysregulation 1
Long-term Considerations
- Monitor for development of metabolic syndrome components:
- Dyslipidemia
- Hypertension
- Glucose intolerance/diabetes
- Assess cardiovascular risk factors regularly
- Consider screening for mood disorders, which are common in PCOS
This pattern of laboratory findings strongly suggests PCOS with insulin resistance as the underlying pathophysiology, requiring lifestyle interventions as the cornerstone of management.